Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Skarka

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Chemico-Biological Interactions|December 28, 2010
Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductaseAdam Skarka, Lucie Skarydová, Hana Stambergová, et al.
Protein Expression and Purification|December 10, 2013
Purification and reconstitution of human membrane-bound DHRS7 (SDR34C1) from Sf9 cellsAdam Skarka, Lucie Škarydová, Hana Štambergová, et al.
Current Drug Metabolism|June 26, 2010
Enzyme stereospecificity as a powerful tool in searching for new enzymesLucie Skarydová, Adam Skarka, Petr Solich, et al.
Biochemical Pharmacology|May 20, 2015
Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductasesJakub Hofman, Adam Skarka, Jana Havrankova, et al.
Chemico-Biological Interactions|March 22, 2017
Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymesPetra Malátková, Adam Skarka, Kateřina Musilová, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 3, 2011
Hydroxysteroid dehydrogenases (HSDs) in bacteria: a bioinformatic perspectiveMichael Kisiela, Adam Skarka, Bettina Ebert, et al.
Toxicology and Applied Pharmacology|May 17, 2014
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3Jakub Hofman, Beata Malcekova, Adam Skarka, et al.
Human & Experimental Toxicology|June 2, 2021
Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell linesVeronika Skarkova, Adam Skarka, Monika Manethova, et al.
Molecules (Basel, Switzerland)|June 21, 2017
The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell LinesMartin Ambrož, Petra Matoušková, Adam Skarka, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 16, 2015
Human DHRS7, promising enzyme in metabolism of steroids and retinoids?Hana Štambergová, Lucie Zemanová, Tereza Lundová, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Chemico-Biological Interactions|December 28, 2010
Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductaseAdam Skarka, Lucie Skarydová, Hana Stambergová, et al.
Protein Expression and Purification|December 10, 2013
Purification and reconstitution of human membrane-bound DHRS7 (SDR34C1) from Sf9 cellsAdam Skarka, Lucie Škarydová, Hana Štambergová, et al.
Current Drug Metabolism|June 26, 2010
Enzyme stereospecificity as a powerful tool in searching for new enzymesLucie Skarydová, Adam Skarka, Petr Solich, et al.
Biochemical Pharmacology|May 20, 2015
Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductasesJakub Hofman, Adam Skarka, Jana Havrankova, et al.
Chemico-Biological Interactions|March 22, 2017
Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymesPetra Malátková, Adam Skarka, Kateřina Musilová, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 3, 2011
Hydroxysteroid dehydrogenases (HSDs) in bacteria: a bioinformatic perspectiveMichael Kisiela, Adam Skarka, Bettina Ebert, et al.
Toxicology and Applied Pharmacology|May 17, 2014
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3Jakub Hofman, Beata Malcekova, Adam Skarka, et al.
Human & Experimental Toxicology|June 2, 2021
Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell linesVeronika Skarkova, Adam Skarka, Monika Manethova, et al.
Molecules (Basel, Switzerland)|June 21, 2017
The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell LinesMartin Ambrož, Petra Matoušková, Adam Skarka, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 16, 2015
Human DHRS7, promising enzyme in metabolism of steroids and retinoids?Hana Štambergová, Lucie Zemanová, Tereza Lundová, et al.
Pageof 4